Report : Europe Radiation Dose Management Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Service/Software (Radiation Dose Management Services and Radiation Dose Management Software), By Medium (Computed Tomography, Radiation and Mammography, Fluoroscopy and Mammography, and Other Medium), and End User (Hospitals, Research and Medical Institutes, and Others)
The hospitals segment by end user is estimated to lead the market growth during the forecast period.
According to a new market research study of “Europe Radiation Dose Management Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Service/Software, Medium, End User and Country.” The Europe radiation dose management market is expected to reach US$ 179.11 million by 2028 from US$ 76.34 million in 2021. It is estimated to grow at a CAGR of 13.0% from 2021 to 2028.The report highlights trends prevailing in the Europe radiation dose management market and the factors driving market along with those that act as hindrances.
The market's growth is due to growing concerns related to radiation exposure and rising cases of cancer demanding radiation therapy. However, organizational challenges and lack of benchmarking for dose optimization is expected to restrict the market growth during the forecast period.
Cancer is one of the leading causes of death in every country and an obstacle to increasing life expectancy. According to a World Health Organization (WHO) 2019 estimate, cancer was the leading or second-leading cause of death in many countries 70 years ago. According to GLOBOCAN 2020, the global burden of cancer is projected to be 28.4 million cases by 2040, a 47% increase since 2020 with tremendous growth due to demographic change. As per the National Library of Medicine, about 30?50% of all cancer patients receive radiation via chemotherapy and surgery. Therefore, around 7 million patients worldwide receive radiation therapy every year.
CT or MRI scans form three-dimensional images of cancer, further enabling accurate targeting for radiation therapy. According to the International Journal of Medical Sciences, radiation therapy is the most effective non-surgical treatment for cancer. It accounts for only 5% of total cancer treatment expenditures. Almost 40% of cancer patients prefer radiation therapy, and the therapy cures 16%. Therefore, the growing number of cancer cases and rising radiation therapy demand are expected to drive the radiation dose management market.
Patients' exposure to radiation has increased significantly over the past two decades. This is due to the increasing number of radiological procedures, such as CT, fluoroscopy, and interventional imaging, and high radiation doses. According to a study by the American Medical Association, the annual increase in CT, MRI, and ultrasound exams was highest between 2000 and 2006. The number increased from 1% to 5% annually between 2012 and 2016 across various age groups. Excess usage of radiation to meet the clinical needs of a procedure may lead to unnecessary radiation exposure. In diagnostic imaging modalities, higher tube currents are generally used for obese patients to improve the image quality.
Due to this, the risk of radiation exposure among obese patients is high. Dose management was never a significant concern for the medical community as their primary focus was to improve image quality (where overexposure yielded better images). Doses of radiation used in procedures have increased, propelling the risk of overexposure to radiation.
Excessive radiation exposure may lead to long-term health consequences. Various concerns have been raised regarding the risks associated with radiation exposure from medical imaging. Additionally, ionizing radiation may damage patients' DNA, and excess exposure may increase the lifetime risk of developing cancer. Millions of exams are performed each year, further making radiation exposure from medical imaging an important public health concern. According to the study, titled understanding the effects of high-dose radiation conducted by the National Institute of Health, it is observed that, in Europe, patients are exposed to excessive radiation during brain scans and the dose received is eight times higher than the average level.
The Europe radiation dose management market, by service or software, is segmented into radiation dose management services and radiation dose management software. The Europe radiation dose management market, by medium, is segmented into computed tomography, radiation, and mammography, fluroscopy and mammography, and other medium. Based on end user, the Europe radiation dose management market is segmented hospitals, research and medical institutes, and others. Geographically, the Europe radiation dose management market can be divided into Germany, UK, France, Italy, Spain and Rest of Europe.
FUJIFILM Holdings Corporation, Bayer AG, Bracco Imaging S.p.A, GE Healthcare, Koninklijke Philips N.V., Medsquare, Novarad Corporation, QAELUM INC, Sectra AB and PACSHealth, LLC are among the leading companies operating in the Europe radiation dose management market.
Contact Person: Sameer Joshi
Email Id: email@example.com